Canfield News

Canfield Scientific Is Celebrating National Innovation Day

  • February 16, 2024
  • Blog

Today is National Innovation Day, in which we celebrate the new advancements and ideas that contribute to the field of science and technology. Canfield Scientific is the global leader in imaging systems for research and healthcare applications. Our difference is science, and we take pride in creating leading technology assets, solving complex skin imaging issues, and redefining how researchers and healthcare professionals approach consultations.  In the past year we have enhanced existing products and introduced new advanced solutions for medical dermatology, plastic surgery, aesthetics, and clinic research industries including:

VEOS®: the only 3D dermatoscope. See lesions in the highest fidelity possible right on your iPhone® Pro. The proVEOS dermatoscope combines Canfield’s superior optics and lighting with Apple’s Super Retina XDR display to provide unsurpassed clarity of skin features across the entire field of view. Use proVEOS with your iPhone Pro for best-in-class skin examinations and experience the future of dermoscopy now.

VEOS iOS app: The new VEOS app improves skin visualization by adding real-time 3D surface contour display and the ability to focus into the depth of the lesion. With one capture, cross-polarized, non-polarized and 3D images are instantly recorded to the patient’s 3D avatar. VEOS apps seamlessly integrate with Canfield Cloud or the local DermaGraphix application.

IntelliStudio®: the new 3rd generation IntelliStudio sets the highest standard for image quality that rivals dermoscopy. A motorized programmable lift, standardized templates, and automated sequencing guide the user through 2D captures – no special photography skills needed. PASI psoriasis module now available.

Canfield makes significant investments in research and development to continue providing the highest quality, state-of-the-art imaging solutions to all of our customers.

Learn more about each of these systems here.